CDC logoSafer Healthier People  CDC HomeCDC SearchCDC Health Topics A-Z
NIOSH - National Institute for Occupational Safety and Health

Skip navigation links Search NIOSH  |  NIOSH Home  |  NIOSH Topics  |  Site Index  |  Databases and Information Resources  |  NIOSH Products  |  Contact Us

Search for NIOSH Publications: NIOSHTIC-2

NIOSHTIC-2 Search Results

      Advanced Search  |  Help  |  About  |  Feedback 
Terms: DB Miller 8 - 8 of 103 Bibliographic entries
Save All   |   Save Page View Saved    |    Download
Select check boxes to automatically save entries, or use 'save all' or 'save page' links above.

 8 Striatal dysregulation of Cdk5 alters locomotor responses to cocaine, motor learning, and dendritic morphology
Authors Meyer-DA; Richer-E; Benkovic-SA; Hayashi-KJ; Kansy-JW; Hale-CF; Moy-LY; Kim-Y; O'Callaghan-JP; Tsai-LH; Greengard-P; Nairn-AC; Cowan-CW; Miller-DB; Antich-P; Bibb-JA 
Source Proc Natl Acad Sci U.S.A. 2008 Nov; 105(47):18561-18566 
Link http://dx.doi.org/10.1073/pnas.0806078105 
NIOSHTIC No. 20034774 
AbstractMotor learning and neuro-adaptations to drugs of abuse rely upon neuronal signaling in the striatum. Cyclin-dependent kinase 5 (Cdk5) regulates striatal dopamine neurotransmission and behavioral responses to cocaine. Although the role for Cdk5 in neurodegeneration in the cortex and hippocampus and in hippocampal-dependent learning has been demonstrated, its dysregulation in the striatum has not been examined. Here we show that strong activation of striatal NMDA receptors produced p25, the truncated form of the Cdk5 co-activator p35. Furthermore, inducible overexpression of p25 in the striatum prevented locomotor sensitization to cocaine and attenuated motor coordination and learning. This corresponded with reduced dendritic spine density, increased neuro-inflammation, altered dopamine signaling, and shifted Cdk5 specificity with regard to physiological and aberrant substrates, but no apparent loss of striatal neurons. Thus, dysregulation of Cdk5 dramatically affects striatal-dependent brain function and may be relevant to non-neurodegenerative disorders involving dopamine neurotransmission. 
KeywordsBrain-function; Drug-receptor; Substance-abuse; Neurological-system; Neuromotor-system; Neurotransmitters; Nerve-fibers; Neurological-reactions; Neurophysiological-effects; Neurophysiology; Neurological-system; Neuromotor-system-disorders 
ContactJames A. Bibb, Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX 75390 
CODENPNASA6 
Publication Date20081125 
Document TypeJournal Article 
Email Addressjames.bibbo@utsouthwestern.edu 
Fiscal Year2009 
NTIS Accession No. 
NTIS Price 
Issue of Publication47 
ISSN0027-8424 
NIOSH DivisionHELD 
Priority AreaServices 
Source NameProceedings of the National Academy of Sciences of the United States of America. 
StateGA; TX; MA; NY; CT 
Page 8 of 103